SecBot SecBot
8-K ·Filed May 1, 2026

CRIS

CURIS INC
BEARISH
Impact 8/10
Horizonimmediate Processed6mo ago SEC0001108205-26-000056
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Traders should expect high volatility ahead of the May 4 appeal deadline and May 6 suspension date. If the appeal is denied or the hearing fails, delisting would likely trigger a sharp sell-off in an already distressed stock. Monitor for any reverse split announcement or capital raise as potential compliance strategies.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$11.60
T+0 close · May 1, 2026 · via day close
Latest settled
−57.07%
T+60 · $4.98
Vs SPY
−58.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 4 $11.60entry
  2. T+1 · 7mo ago −1.72%α −2.53% · $11.40
  3. T+5 · 6mo ago −5.17%α −8.14% · $11.00
  4. T+20 · 6mo ago −13.79%α −19.58% · $10.00
  5. T+60 · 4mo ago −57.07%α −58.93% · $4.98

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Curis received a Nasdaq delisting determination letter on April 27, 2026, because its common stock bid price closed below $1.00 for 30 consecutive business days. The company intends to appeal by requesting a hearing before May 4, 2026, which would stay the suspension scheduled for May 6, but there is no assurance the appeal will succeed. This filing follows a prior discretionary panel monitor period, meaning Curis has limited procedural flexibility to regain compliance.

Key Facts

  • Nasdaq issued a Delist Determination Letter on April 27, 2026 for non-compliance with the $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).
  • Stock had closed below $1.00 for 30 consecutive business days.
  • Trading suspension scheduled for May 6, 2026 unless an appeal is filed by May 4, 2026.
  • Company was already under a one-year Discretionary Panel Monitor (since Feb 3, 2026), limiting its ability to request additional compliance periods.
  • Company intends to request a hearing to stay delisting, but success is uncertain.
  • Market cap is approximately $24M, making the company highly vulnerable to delisting consequences.

Financial Impact

Delisting would severely reduce institutional ownership and liquidity for a $24M market cap company. No specific financial figures provided in filing.

liquidityinstitutional ownershipstock price

Risk Factors

  • Delisting would cut off institutional access and severely reduce liquidity.
  • Company is already under a Panel Monitor, limiting its ability to negotiate compliance extensions.
  • No guarantee the Nasdaq hearing panel will grant continued listing.
  • At $24M market cap, the company has limited financial flexibility to engineer a compliance solution.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001108205-26-000056
Document: 0001108205-26-000056-index-headers.html0001108205-26-000056
Document: 0001108205-26-000056-index.html0001108205-26-000056
Document: 0001108205-26-000056.txt0001108205-26-000056

Track record

18 reports on CRIS

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
  3. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
  4. Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
  5. Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
  6. Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
  7. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
  8. Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
  9. Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
  10. Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026